Add like
Add dislike
Add to saved papers

Association of serum Ninjurin2 levels with neurologic damage and postherpetic neuralgia occurrence: an observational cohort study in chinese herpeszoster patients.

Oncotarget 2017 September 23
OBJECTIVES: Postherpetic neuralgia(PHN) is the most common complication of herpeszoster (HZ) infection. The study aimed to explore whether serum Ninjurin2 (for nerve injury-induced protein 2, NINJ2), a novel neurologic damage related protein, is associated with nerve injury and the occurrence of PHN.

RESULTS: Seventy-four of the eighty patients completed the study. On the 7th day of AHN, the patients had significantly higher values of NINJ2, cold-sense dispersion (ΔCS), warm-sense dispersion (ΔWS), cold-pain dispersion (ΔCP), heat-pain dispersion (ΔHP) and NRS score compared to controls. Six months after herpes, thirty four patients developed PHN. The values of serum NINJ2, ΔCS, ΔWS, ΔCP and ΔHP in PHN patients remained higher than in the controls and the patients who did not develop PHN. The PHN patients had significantly lower values of serumNINJ2 than patients who did not develop PHN in the period of AHN. With partial correlations and multivariable logistic regressions, serum NINJ2 level was strongly predictive of PHN.

MATERIALS AND METHODS: Eighty individuals with acute herpetic neuralgia (AHN) and 60 controls were recruited. The following nerve injury testing was performed on all of the patients including: the numerical rating scale (NRS) test, quantitative sensory testing (QST), and the investigation of serum NINJ2 levels on the 7th day of AHN; in addition, all of the patients repeated all of the items at 6 months after herpes.

CONCLUSIONS: The serum NINJ2 levels are associated with nerve injury, particularly with nerve recovery, and may be predictors of PHN occurrence.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app